BCM
CNXC icon

Bayesian Capital Management’s Concentrix CNXC Stock Holding History

Bayesian Capital Management’s Portfolio CNXC Stock Details CNXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,400
Closed -$300K – 596
2025
Q1 		$300K Buy
+5,400
New +$259K 0.05% 388
2024
Q2 		– Sell
-9,936
Closed -$658K – 800
2024
Q1 		$658K Buy
+9,936
New +$807K 0.06% 380
2023
Q3 		– Sell
-6,600
Closed -$533K – 739
2023
Q2 		$533K Buy
+6,600
New +$617K 0.06% 389
2022
Q4 		– Sell
-2,858
Closed -$319K – 821
2022
Q3 		$319K Buy
+2,858
New +$366K 0.06% 399

Other funds holding CNXC

GBL
Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bayesian Capital Management's CNXC Position: Q2 2025 in Review

Bayesian Capital Management sold out of Concentrix (CNXC) in Q2 2025, closing a stake of 5,400 shares — an estimated $300K sold.

Bayesian Capital Management first reported a position in CNXC in Q3 2022 and held it in 4 quarters. The position peaked at $658K in Q1 2024. 335 funds tracked by Wall St. Rank hold CNXC as of Q2 2025.

  • Bayesian Capital Management reported no remaining Concentrix position as of Q2 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 5,400 Concentrix shares in Q2 2025, an estimated $300K.
  • Bayesian Capital Management first reported a position in Concentrix in Q3 2022 and held it in 4 quarters.
  • Bayesian Capital Management's Concentrix position peaked at $658K in Q1 2024.
  • 335 funds tracked by Wall St. Rank held Concentrix as of Q2 2025.

Based on Bayesian Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.